Answer
Yes, Inaqovi is contraindicated during breast-feeding because it is unknown whether decitabine, cedazuridine or their metabolites enter breast milk, and a risk to newborns or infants cannot be excluded.
Sources for this answer
- Inaqovi 35 mg/100 mg film coated tabletsOtsuka Pharmaceuticals (UK) Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked